pexacerfont   Click here for help

GtoPdb Ligand ID: 10379

Synonyms: BMS-562086 | BMS562086
Compound class: Synthetic organic
Comment: Pexacerfont (BMS-562086) is an orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 77.23
Molecular weight 340.2
XLogP 3.38
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES CCC(Nc1nc(C)nc2n1nc(c2c1ccc(nc1C)OC)C)C
Isomeric SMILES CC[C@H](Nc1nc(C)nc2n1nc(c2c1ccc(nc1C)OC)C)C
InChI InChI=1S/C18H24N6O/c1-7-10(2)19-18-22-13(5)21-17-16(12(4)23-24(17)18)14-8-9-15(25-6)20-11(14)3/h8-10H,7H2,1-6H3,(H,19,21,22)/t10-/m1/s1
No information available.
Summary of Clinical Use Click here for help
Pexacerfont (BMS-562086) was progressed to Phase 2/3 evaluation in patients with generalized anxiety disorder (see NCT00481325).
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT00481325 Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder Phase 2/Phase 3 Interventional Bristol-Myers Squibb